Organic compounds -- part of the class 532-570 series – Organic compounds – Pteroyl per se or having -c- – wherein x is chalcogen – bonded...
Reexamination Certificate
2007-02-13
2007-02-13
Habte, Kahsay (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Pteroyl per se or having -c-, wherein x is chalcogen, bonded...
C544S118000, C544S357000, C546S275400
Reexamination Certificate
active
10753199
ABSTRACT:
A process for the preparation of Compounds of the formula (1):wherein R1, R2, R4and R13are as defined or a pharmaceutically or veterinarily acceptable salt or polymorph thereof, or a pharmaceutically or veterinarily acceptable solvate or pro-drug thereof: are potent and selective inhibitors of type 5 cyclic guanosine 3′,5′-monophosphate phosphodiestbrase (cGMP PDE5) and have utility in the treatment of, inter alia, male erectile dysfunction (MED) and female sexual dysfunction (FSD).
REFERENCES:
patent: 2089971 (1937-08-01), Lesser
patent: 4663326 (1987-05-01), Hamilton
patent: 4666908 (1987-05-01), Hamilton
patent: 4871843 (1989-10-01), Roger et al.
patent: 5250534 (1993-10-01), Bell et al.
patent: 5272147 (1993-12-01), Bell et al.
patent: 5294612 (1994-03-01), Bacon et al.
patent: 5346901 (1994-09-01), Bell et al.
patent: 5426107 (1995-06-01), Bell et al.
patent: 5719283 (1998-02-01), Bell et al.
patent: 5734053 (1998-03-01), Terrett
patent: 5736548 (1998-04-01), Bacon et al.
patent: 5955611 (1999-09-01), Dunn et al.
patent: 6420557 (2002-07-01), Harris et al.
patent: 6699991 (2004-03-01), James et al.
patent: 2002/0040140 (2002-04-01), Harris et al.
patent: 19540642 (1997-05-01), None
patent: 0201188 (1986-12-01), None
patent: 0352960 (1990-01-01), None
patent: 0463756 (1992-01-01), None
patent: 0526004 (1993-02-01), None
patent: 0349239 (1994-03-01), None
patent: 0636626 (1995-02-01), None
patent: 0425921 (1995-08-01), None
patent: 0812845 (1997-12-01), None
patent: 0992240 (2000-04-01), None
patent: 0995750 (2000-04-01), None
patent: 1020190 (2000-07-01), None
patent: 1074258 (2001-02-01), None
patent: 1090644 (2001-04-01), None
patent: 1092720 (2001-04-01), None
patent: 2000119198 (2000-04-01), None
patent: WO 9306104 (1993-04-01), None
patent: WO 9307149 (1993-04-01), None
patent: WO 9312095 (1993-06-01), None
patent: WO 9315062 (1993-08-01), None
patent: WO 9400453 (1994-01-01), None
patent: WO 9405661 (1994-03-01), None
patent: WO 9428902 (1994-12-01), None
patent: WO 9509636 (1995-04-01), None
patent: WO 9616644 (1996-06-01), None
patent: WO 9616657 (1996-06-01), None
patent: WO 9628429 (1996-09-01), None
patent: WO 9628448 (1996-09-01), None
patent: WO 9843614 (1998-10-01), None
patent: WO 9049166 (1998-11-01), None
patent: WO 9852569 (1998-11-01), None
patent: WO 9930697 (1999-06-01), None
patent: WO 9954333 (1999-10-01), None
patent: WO 9959584 (1999-11-01), None
patent: WO 9964004 (1999-12-01), None
patent: WO 0020033 (2000-04-01), None
patent: WO 0023056 (2000-04-01), None
patent: WO 0024745 (2000-05-01), None
patent: WO 0037061 (2000-06-01), None
patent: WO 0044399 (2000-08-01), None
patent: WO 0053148 (2000-09-01), None
patent: WO 0108659 (2001-02-01), None
patent: WO 0110406 (2001-02-01), None
patent: WO 0127113 (2001-04-01), None
Czarmiecki et al, Annual Reports in Medicinal Chemistry, 31, 61-70, Dec. (1996).
Henze et al., J. Am. Chem. Soc., Feb. 1939, pp. 433-435.
Terfort et al., J. Chem. Soc. Perkin trans. 1, 1996, pp. 1467-1479.
Dumaltre, J. Med. Chem., 1996, 39, 1635-1644.
Terrett, et al., Bioorg. Med. Chem. Lett, vol. 6, No. 15, 1996, pp. 1819-1824.
Gazz. Chim. Ital., vol. 72, 1942, pp. 325-333.
Hamilton et al., J. Med. Chem. vol. 30, No. 1, 1987, pp. 91-96.
Billotte, SYNLETT, Apr. 1998, pp. 379-380.
Jung, et al., Org. Chem. vol. 56, No. 24, 1991.
Anderson et al., J. org. Chem., vol. 37, No. 24, 1972, pp. 3953-3955.
Byeongmoon, et al., Nature, vol. 388, No. 28, pp. 860-862, Aug. 1997.
Hostyn, et al., J. Fr. Opthalmol., vol. 19, No. 2, pp. 133-139, 1996.
Hye Jung Lee et al., The J. of Pharmacology, vol. 281, No. 3, pp. 1431-1439, 1997.
OluFunmi et al., Nature Medicine, vol. 2, No. 7, pp. 795-799, Jul. 1996.
Takada et al., PDA Jrnl of Pharm. Science and Tech., vol. 49 No. 4, pp. 180-184, Jul.-Aug. 1995.
Bunnage Mark Edward
DeVries Keith Michael
Harris Laurence James
Levett Philip Charles
Mathias John Paul
Benson Gregg C.
Habte Kahsay
Munchhof Martha G.
LandOfFree
Process for preparing pharmaceutically active compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing pharmaceutically active compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing pharmaceutically active compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3853760